Coherus Oncology (CHRS) News Today $1.61 +0.04 (+2.55%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$1.62 +0.00 (+0.31%) As of 05/22/2026 07:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CHRS Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2026 April 2026 March 2026 February 2026 January 2026 December 2025 November 2025 October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 Time Period Coherus Biosciences Signals Confident Oncology Earnings OutlookMay 14, 2026 | theglobeandmail.comWhat You Need To Know About The Coherus Oncology, Inc. (NASDAQ:CHRS) Analyst Downgrade TodayMay 14, 2026 | finance.yahoo.comCoherus Oncology (NASDAQ:CHRS) Research Coverage Started at GuggenheimMay 14, 2026 | americanbankingnews.comCoherus Oncology: Setting Up For Important Readouts In Mid-2026May 13, 2026 | seekingalpha.comCoherus Oncology, Inc.: Coherus Oncology Reports First Quarter 2026 Financial Results and Provides Business UpdateMay 12, 2026 | finanznachrichten.deGuggenheim initiates coverage of Coherus Oncology (CHRS) with buy recommendationMay 12, 2026 | msn.comCoherus Oncology, Inc. (CHRS) Q1 2026 Earnings Call TranscriptMay 12, 2026 | seekingalpha.comCoherus Oncology Reports First Quarter 2026 Financial Results and Provides Business UpdateMay 11, 2026 | finance.yahoo.comCoherus Oncology Q1 Earnings Call HighlightsMay 11, 2026 | marketbeat.comCoherus Oncology (CHRS) Projected to Post Quarterly Earnings on MondayMay 4, 2026 | marketbeat.comCoherus Oncology to Report First Quarter 2026 Financial Results on May 11, 2026May 4, 2026 | markets.businessinsider.comCoherus Oncology to Report First Quarter 2026 Financial Results on May 11, 2026May 4, 2026 | globenewswire.comCoherus Oncology (NASDAQ:CHRS) Stock Price Crosses Above 200-Day Moving Average - Here's WhyMay 2, 2026 | marketbeat.comCoherus Oncology (NASDAQ:CHRS) Share Price Passes Above 200 Day Moving Average - Here's WhyApril 24, 2026 | marketbeat.comCoherus Oncology (CHRS) is one of the best penny stocks, here is why – correctedApril 10, 2026 | msn.comWhy The Coherus Oncology (CHRS) Story Is Shifting Around Growth Assumptions And Execution RiskApril 1, 2026 | finance.yahoo.comCoherus Biosciences (CHRS) Is One of the Best Penny Stocks, Here is WhyMarch 31, 2026 | msn.comCoherus Oncology Reports Full Year and Fourth Quarter 2025 Financial Results and Provides Business UpdateMarch 11, 2026 | markets.businessinsider.comCoherus Oncology, Inc.: Coherus Oncology Reports Full Year and Fourth Quarter 2025 Financial Results and Provides Business UpdateMarch 10, 2026 | finanznachrichten.deCoherus Oncology Inc (CHRS) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and ...March 10, 2026 | finance.yahoo.comCoherus Oncology, Inc. (CHRS) Q4 2025 Earnings Call TranscriptMarch 9, 2026 | seekingalpha.comCoherus Oncology Reports Full Year and Fourth Quarter 2025 Financial Results and Provides Business UpdateMarch 9, 2026 | globenewswire.comHow The Coherus Oncology (CHRS) Narrative Is Evolving Around Clinical Catalysts And Valuation RisksMarch 5, 2026 | finance.yahoo.comCoherus Oncology, Inc. to Release 2025 Financial Results on March 9, 2026, with Conference Call to FollowMarch 2, 2026 | quiverquant.comQCoherus Oncology to Report Full Year and Fourth Quarter 2025 Financial Results on March 9, 2026March 2, 2026 | globenewswire.comCoherus Oncology to Participate in Upcoming Investor ConferencesFebruary 23, 2026 | globenewswire.comCoherus: Downgrade To 'Hold' On Potential Advancement Of Anti-CCR8 CHS-114February 20, 2026 | seekingalpha.comHow Recent Developments Are Rewriting The Story For Coherus Oncology (CHRS)February 18, 2026 | finance.yahoo.comCoherus Biosciences Completes $47 Million Equity OfferingFebruary 17, 2026 | tipranks.comCoherus Oncology, Inc. Announces Closing of Public Offering of Common StockFebruary 17, 2026 | globenewswire.comCoherus BioSciences stock falls after pricing $50.1 million share offeringFebruary 13, 2026 | in.investing.comCoherus Oncology prices stock offering to raise $50.1MFebruary 13, 2026 | msn.comCoherus Oncology, Inc. Announces Proposed Public Offering of Common StockFebruary 13, 2026 | finance.yahoo.comCoherus Oncology, Inc. Announces Pricing of $50.1 Million Public Offering of Common StockFebruary 12, 2026 | quiverquant.comQCoherus Oncology, Inc. Announces Pricing of Public Offering of Common StockFebruary 12, 2026 | globenewswire.comCoherus Signs Clinical Supply Deal With Janssen OncologyFebruary 10, 2026 | theglobeandmail.comCoherus Oncology (CHRS) Is Up 28.7% After ATM Offering And Bullish Coverage - What's ChangedJanuary 26, 2026 | finance.yahoo.comCoherus Biosciences Updates ATM Equity Offering ProgramJanuary 23, 2026 | tipranks.comOppenheimer initiates coverage of Coherus Oncology (CHRS) with outperform recommendationJanuary 23, 2026 | msn.comCoherus Oncology stock soars 35% after Oppenheimer initiates with massive upsideJanuary 23, 2026 | in.investing.comCoherus Oncology Sees Unusually Large Options Volume (NASDAQ:CHRS)January 23, 2026 | marketbeat.comCoherus Oncology, Inc. (CHRS) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptJanuary 13, 2026 | seekingalpha.comCoherus Management to Present at the 44th Annual J.P. Morgan Healthcare ConferenceJanuary 6, 2026 | globenewswire.comCoherus Oncology announces publication highlighting CCR8 antibody tagmokitugJanuary 5, 2026 | msn.comCoherus Oncology Introduces Tagmokitug: Promising Results from CCR8-targeting Antibody ResearchJanuary 5, 2026 | quiverquant.comQCoherus Oncology Announces Publication in Molecular Cancer Therapeutics Highlighting the Strong Pharmacology of Investigational CCR8 Antibody Tagmokitug (CHS-114)January 5, 2026 | globenewswire.comCoherus Oncology: A Two-Pronged March With Mid-2026 ImplicationsDecember 23, 2025 | seekingalpha.comCoherus Oncology (CHRS) price target increased by 13.33% to 5.78December 21, 2025 | msn.comCoherus BioSciences stock jumps after positive cancer drug survival dataDecember 8, 2025 | za.investing.comCoherus Oncology announces six-year OS results from Phase 3 JUPITER-02 trialDecember 8, 2025 | msn.com Get Coherus Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for CHRS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CHRS Media Mentions By Week CHRS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CHRS News Sentiment▼0.000.44▲Average Medical News Sentiment CHRS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CHRS Articles This Week▼02▲CHRS Articles Average Week Get the Latest News and Ratings for CHRS and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Coherus Oncology and its competitors. Sign Up View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Pharming Group News Design Therapeutics News Schrodinger News MeiraGTx News Sana Biotechnology News Annexon News LB Pharmaceuticals News Janux Therapeutics News Oric Pharmaceuticals News Arbutus Biopharma News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CHRS) was last updated on 5/23/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | SponsoredSatellite Images Spot Potential $10 Trillion Discovery'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...Altimetry | SponsoredThe AI stocks about to become worthless (and one that isn't)Louis Navellier - who manages $1.1 billion including $358 million in AI stocks - says a new AI computer being ...InvestorPlace | SponsoredSpaceX will mint billionaires. You won't be one of them.By the time a company goes public, 95% of profits have already been made. Insiders bought SpaceX at $20 billio...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Coherus Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Coherus Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
